Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Original Research

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective

       
Total article views   HTML views PDF downloads Totals
12,651 Dovepress* 11,484+ 2,116 13,600
PubMed Central* 1,167 482 1,649
Totals 12,651 2,598 15,249
*Since 23 August 2012
+Since July 2016

View citations on PubMed Central and Google Scholar